Evidence map›Paper›PMID 34680946›Full record

ArticleGenes2021

YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level.

Antonella Delicato, Eleonora Montuori, Tiziana Angrisano, Alessandra Pollice, Viola Calabrò

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. KenyanPlants (Basel, Switzerland) · 2025
    Article
  4. FBXW11 inhibits tumorigenesis by ubiquitinating YB1 in hepatocarcinoma.Journal of cancer research and clinical oncology · 2025
    Article
  5. Review
  6. YB1 and its role in osteosarcoma: a review.Frontiers in oncology · 2024
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Antonella DelicatoDepartment of Biology, University of Naples Federico II, MSA-Via Cinthia, 26-80126 Naples, Italy.ORCID 0000-0002-8268-2038
Eleonora MontuoriDepartment of Biology, University of Naples Federico II, MSA-Via Cinthia, 26-80126 Naples, Italy.
Tiziana AngrisanoDepartment of Biology, University of Naples Federico II, MSA-Via Cinthia, 26-80126 Naples, Italy.ORCID 0000-0002-5940-5278
Alessandra PolliceDepartment of Biology, University of Naples Federico II, MSA-Via Cinthia, 26-80126 Naples, Italy.
Viola CalabròDepartment of Biology, University of Naples Federico II, MSA-Via Cinthia, 26-80126 Naples, Italy.ORCID 0000-0002-6508-8889
University of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

YB-1 is a multifunctional protein overexpressed in many types of cancer. It is a crucial oncoprotein that regulates cancer cell progression and proliferation. Ubiquitously expressed in human cells, YB-1 protein functions are strictly dependent on its subcellular localization. In the cytoplasm, where YB-1 is primarily localized, it regulates mRNA translation and stability. However, in response to stress stimuli and activation of PI3K and RSK signaling, YB-1 moves to the nucleus acting as a prosurvival factor. YB-1 is reported to regulate many cellular signaling pathways in different types of malignancies. Furthermore, several observations also suggest that YB-1 is a sensor of oxidative stress and DNA damage. Here we show that YB-1 reduces PTEN intracellular levels thus leading to PI3K/Akt pathway activation. Remarkably, PTEN reduction mediated by YB-1 overexpression can be observed in human immortalized keratinocytes and HEK293T cells and cannot be reversed by proteasome inhibition. Real-time PCR data indicate that YB-1 silencing up-regulates the PTEN mRNA level. Collectively, these observations indicate that YB-1 negatively controls PTEN at the transcript level and its overexpression could confer survival and proliferative advantage to PTEN proficient cancer cells.

Indexed as

HaCaT CellsHEK293 CellsHumansPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseSignal TransductionY-Box-Binding Protein 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseY-Box-Binding Protein 1YBX1 protein, humancold-shock proteinsPI3K/Akt pathwayproteasomePTENYB-1

Identifiers

PMID34680946
PMCPMC8535809
OpenAlexW3203962414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.